WCM Investment Management Portfolio holdings
AUM
$43.8B
This Quarter Return
+10.69%
1 Year Return
+46.92%
3 Year Return
+145.55%
5 Year Return
+234.7%
10 Year Return
+793.48%
AUM
$44.4B
AUM Growth
+$44.4B
(+2.6%)
Cap. Flow
-$2.21B
Cap. Flow
% of AUM
-4.98%
Top 10 Holdings %
Top 10 Hldgs %
56.1%
Holding
220
New
16
Increased
134
Reduced
52
Closed
15
Top Buys
| 1 |
Novo Nordisk
NVO
|
$278M |
| 2 |
Lam Research
LRCX
|
$184M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
$138M |
| 4 |
Nu Holdings
NU
|
$114M |
| 5 |
Endava
DAVA
|
$39.5M |
Top Sells
| 1 |
Mercado Libre
MELI
|
$2.2B |
| 2 |
HDFC Bank
HDB
|
$1.08B |
| 3 |
Atlassian
TEAM
|
$285M |
| 4 |
Credicorp
BAP
|
$29.4M |
| 5 |
TWKS
Thoughtworks Holding, Inc. Common Stock
TWKS
|
$24.5M |
Sector Composition
| 1 | Technology | 40.57% |
| 2 | Healthcare | 28.38% |
| 3 | Industrials | 9.53% |
| 4 | Consumer Discretionary | 9.23% |
| 5 | Financials | 5.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LHCG
126
DELISTED
LHC Group LLC
LHCG
| $11.2M | 0.03% |
81,811
+23,823
| +41% | +$3.27M |
|
|
127
HDFC Bank
HDB
$181B
| $11.2M | 0.03% |
171,811
-16,556,407
| -99% | -$1.08B |
|
128
V2X
VVX
$1.74B
| $10.6M | 0.02% |
230,809
-770
| -0.3% | -$35.2K |
|
129
Elastic
ESTC
$9.17B
| $10.4M | 0.02% |
84,554
+29,122
| +53% | +$3.58M |
|
130
Saic
SAIC
$5.35B
| $10.4M | 0.02% |
123,841
+4,236
| +4% | +$354K |
|
131
Health Catalyst
HCAT
$228M
| $9.99M | 0.02% |
+252,190
| New | +$9.99M |
|
132
Mercury Systems
MRCY
$4.05B
| $9.91M | 0.02% |
180,021
+13,382
| +8% | +$737K |
|
|
NSTG
133
DELISTED
NanoString Technologies, Inc.
NSTG
| $9.32M | 0.02% |
220,586
+98,426
| +81% | +$4.16M |
|
|
SWAV
134
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $9.22M | 0.02% |
51,700
-8,464
| -14% | -$1.51M |
|
|
BHVN
135
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $8.93M | 0.02% |
64,771
+3,737
| +6% | +$515K |
|
136
CryoPort
CYRX
$426M
| $8.82M | 0.02% |
148,974
+6,197
| +4% | +$367K |
|
137
Sprout Social
SPT
$896M
| $8.71M | 0.02% |
96,019
-361
| -0.4% | -$32.7K |
|
138
Arrowhead Research
ARWR
$3.84B
| $8.63M | 0.02% |
130,196
+10,855
| +9% | +$720K |
|
139
AtriCure
ATRC
$1.73B
| $8.35M | 0.02% |
120,055
+6,641
| +6% | +$462K |
|
140
LivePerson
LPSN
$86M
| $8.15M | 0.02% |
228,131
+4,983
| +2% | +$178K |
|
141
Natera
NTRA
$23B
| $8.02M | 0.02% |
85,921
+20,640
| +32% | +$1.93M |
|
|
CCF
142
DELISTED
Chase Corporation
CCF
| $7.97M | 0.02% |
80,075
-325
| -0.4% | -$32.4K |
|
143
Upland Software
UPLD
$78.3M
| $7.12M | 0.02% |
396,702
+39,186
| +11% | +$703K |
|
144
Pacific Biosciences
PACB
$378M
| $6.92M | 0.02% |
338,246
+36,012
| +12% | +$737K |
|
|
ONEM
145
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $6.91M | 0.02% |
393,412
+20,778
| +6% | +$365K |
|
146
Insmed
INSM
$30.3B
| $6.6M | 0.01% |
242,175
+16,360
| +7% | +$446K |
|
147
Ultragenyx Pharmaceutical
RARE
$3.04B
| $6.45M | 0.01% |
76,709
+3,297
| +4% | +$277K |
|
148
Toast
TOST
$24.7B
| $6.01M | 0.01% |
172,992
+9,866
| +6% | +$342K |
|
149
Fate Therapeutics
FATE
$119M
| $5.91M | 0.01% |
100,928
+7,307
| +8% | +$428K |
|
150
HEICO
HEI
$44.4B
| $5.86M | 0.01% |
40,640
+13,370
| +49% | +$1.93M |
|